Article Text
Unexpected outcome (positive or negative) including adverse drug reactions
CASE REPORT
Citrobacter freundii sepsis in an immunosuppressed patient with pemphigus vulgaris
Abstract
Pemphigus vulgaris is an autoimmune bullous disease that involves the skin and mucous membranes. Current therapies aim to decrease antibody production by means of the use of systemic corticosteroids, immunosuppressive agents and, recently, rituximab, an anti-CD20 monoclonal antibody. However, the chronic immune suppression could entail complications, like infections and secondary malignancies. We describe a case of a patient with pemphigus who developed a sepsis due to Citrobacter freundii infection.
- dermatology
- infections